Rapport Therapeutics logo

Rapport Therapeutics

Boston, MA

Rapport Therapeutics operates as a clinical-stage biotechnology company, that discovers and develops precision medicines for neurological disorders. Rapport Therapeutics describes relationships that are defined by understanding, communication, teamwork, and trust.

rapportrx.com

Company Details

Founded

2022

Employees

Between 50 - 100 employees

Raised

$250,000,000

Headquarters Location

Boston, MA

Public

Yes

Acquired

No

CEO

Abraham (Abe) CeesayAbraham (Abe) Ceesay

Founders

David Bredt
David Bredt
Steven Paul
Steven Paul

Company Collections

These are collections Rapport Therapeutics is a part of. Click on the collection name to view similar companies.

Rapport Therapeutics' Industries

Rapport Therapeutics' Tech Stack

Current Job Listings

Listing 0 of 5 job openings

    Rapport Therapeutics Headquarters Location

    201 Brookline Avenue suite 1401, Boston, MA 02215

    Total Amount Raised: $250,000,000

    Rapport Therapeutics Funding Rounds

    • IPO

      Unknown

    • Series B

      $150,000,000

      Series B Investors

      Cormorant Asset Management
      Arch Venture Partners
      Fidelity
      Logos Capital
      Third Rock Ventures
      Perceptive Advisors
      Goldman Sachs Asset Management
      Surveyor Capital
      Johnson & Johnson Innovation
      Sofinnova Ventures
      T. Rowe Price

    • Series A

      $100,000,000

      Series A Investors

      Third Rock Ventures
      Arch Venture Partners
      Johnson & Johnson Innovation
    Funding info provided by Diffbot.

    Rapport Therapeutics Reviews

    0 out of 5 stars

    Based on 0 reviews

    Review data

    Share your thoughts

    Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Rapport Therapeutics.

    Recent reviews